Addiction
Social

The opioid crisis: When will America stand up to addiction?

To what extent is America challenged in the current opioid crisis? President Trump went as far as to donate a portion of his salary to raise awareness and declared war on opioids so this must be serious right? To put things into perspective: In 2016 the US saw an increase of 17.7% in citizen deaths that were all related to drug overdose – the number was pegged at 64 000 deaths. Whereas other countries also suffer, the US faces the most significant challenge. Could you even imagine that the US has 5% of the worlds’ population but accounts for 80% of global opioid consumption? That tells us the something is seriously wrong and an expedited solution is needed. If other countries have a smaller problem than the US but many – including Europe, resorted to Ibogaine treatment, the question is this: Why is Ibogaine treatment still not available in the US?

The US faces a complex battle against addiction

Indeed many argue that the addiction crisis were sparked by prescription drugs. More specifically, due to the aggressive marketing of painkillers produced from opium poppy. It does not help either that healthcare professionals are frequently recruited as advocates. Now this involve drugs like Oxycontin / Oxycodene and Buprenorphine. Concerning the things that the US would like to resolve with a big wall: well, here we’re talking about drugs like cocaine, heroin, methadone and methamphetamine. Clearly the wall will not tackle painkillers and congress will have some work to do. It is understandable that some feel the system is failing them and they look at Europeans and Mexicans with envy. Family members of those who suffer addiction have expressed a more harsh line against “government inaction” as many people need to travel abroad for treatment with Ibogaine.

It seems that most Americans travel to Mexico for Ibogaine treatment

We caught up with a very interesting lady Laura Shapiro, the Director of Admissions at Clear Sky Recovery. Of interest was the insights she shared about how people managed to claim back their lives from addiction. At first sight, the written testimonials of people was notable. In digging for some more Clear Sky ibogaine reviews it emerged that they also have an archive of video testimonials of people who succeeded in curing addiction. However this is not some fiction or elementary rehab: It is overseen by Doctor Alberto Sola, the Medical Director who has a team of medical experts at Clear Sky. What could be seen on the video interviews are consistent with research claims that dates back as far as 1900 – and recent medical journals. There is a historic timeline for Ibogaine research available on the Clear Sky website. It also claims that the facility had in excess of 3800 treatment episodes with zero Ibogaine-related fatalities. This is a noteworthy statistic for individuals who are searching for a fast cure to various types of addiction.

What do we know about Ibogaine research today?

In France it was already available in 1930. At the time, it was sold under a pharmaceutical label called Lambarene. After France discontinued the use of the drug, other countries persisted with for example Mexico, Panama and St. Kitts. It is also said that the founders of Clear Sky were the only people to date, who at one point had permission to carry out trials patients who suffered from addiction in the US. Ibogaine is actually a naturally occurring alkaloid that comes from the roots of the African rain forest. It is believed that pharmaceutical companies were not convinced of the commercial viability of Ibogaine, particularly as research indicates it is not addictive. As a consequence of years of research, the medical team at Clear Sky said “We can unequivocally state that ibogaine has anti-addictive properties”.

Treatment philosophy: As it happens in other parts of the world

So far, what transpired after many years of treatment and research abroad, a theory has emerged on how Ibogaine treats addiction. In cases of addiction, the brain is sending out craving signals to the body. Once administered under medical supervision, Ibogaine can temporarily modify the brain so these signals are interrupted. As it is a psychoactive substance, therapists can guide the patient in a new direction of self-discovery. But those who were involved with Ibogaine treatment for many years have come forward to talk about it. Patrick Kroupa, a consultant at Clear Sky appeared at a panel interview and said the following: “the people who did the best long-term, were those who fill out the huge black hole that used to be occupied by drugs”. This is indeed important to remember concerning the road to full long-term recovery.

Conclusion:

The drug epidemic is substantial and people everywhere want to stop heroine or oxycontin addiction quickly. They want to overcome cocaine addiction too. Ibogaine detox is emerging as other countries took leadership on this. We now see more and more testimonials around the world that seems consistent with research claims. So will the US get involved eventually? One thing that is clear, is that self-treatment is not an area any individual should consider. If any Ibogaine treatment is prescribed, the only way would have to be under medical supervision. For long term results, ultimate lifestyle changes need to be made under the right guidance. What the future holds for Ibogaine in the US is unclear. In the meantime, it seems that Mexico and Europe will continue to lead in this field.

Medical and academic research papers on Ibogaine:

http://www.iceers.org/docs/science/iboga/Ibogaine%20Proceedings/ch08_Heroin_Kamlet.pdf

http://ibogaine.mindvox.com/wp-content/uploads/2014/05/Mash-01.pdf

https://www.researchgate.net/publication/13615627_Medication_development_of_ibogaine_as_a_pharmacotherapy_for_drug_dependence

http://www.sciencedirect.com/science/article/pii/S0968089602005242